Iterum Therapeutics PLC (ITRM) — DEF 14A Filings
All DEF 14A filings from Iterum Therapeutics PLC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Iterum Therapeutics Details Executive Equity Awards in DEF 14A
— Jul 29, 2025 Risk: medium
Iterum Therapeutics plc's DEF 14A filing for the period ending December 31, 2024, primarily focuses on executive compensation and equity awards, rather than pro -
Iterum Therapeutics plc Announces 2024 Annual General Meeting of Shareholders
— Apr 26, 2024 Risk: low
Iterum Therapeutics plc (ITRM) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual General Meeting of Shareholders for Iterum Ther
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX